These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18249310)

  • 1. Severe hemorrhagic syndrome due to similarity of drug names.
    Chiche L; Thomas G; Canavese S; Branger S; Jean R; Durand JM
    Eur J Intern Med; 2008 Mar; 19(2):135-6. PubMed ID: 18249310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use the INN to avoid confusion between drugs.
    Prescrire Int; 2009 Oct; 18(103):214. PubMed ID: 19882793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe overdose in vitamin K antagonist secondary to grapefruit juice absorption].
    Desmard M; Hellmann R; Plantefève G; Mentec H
    Ann Fr Anesth Reanim; 2009 Oct; 28(10):897-9. PubMed ID: 19766437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication errors caused by confusion of drug names.
    Hoffman JM; Proulx SM
    Drug Saf; 2003; 26(7):445-52. PubMed ID: 12735783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
    Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
    Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serious complication of an illegible prescription].
    Alzieu M; Trivin F; Guglielminotti J; Guidet B; Offenstadt G
    Presse Med; 2000 Jun; 29(22):1263. PubMed ID: 10916541
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.
    Béné J; Dubart AE; Senis C; Auffret M; Caron J; Gautier S
    J Mal Vasc; 2014 Jul; 39(4):248-55. PubMed ID: 24889788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication errors and look-alike tablets: the splitting issue.
    Tranchard F; Hein C; Lacombe J; Villars H; Montastruc JL; Despas F
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1002-3. PubMed ID: 27418372
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diffuse alveolar hemorrhage secondary to oral anticoagulant use].
    Léna H; Desrues B; Quinquenel ML; Gacouin A; Caulet-Maugendre S; Briens E; Lopes C; Delaval P
    Rev Mal Respir; 1995; 12(5):496-8. PubMed ID: 8560083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between paracetamol and oral anticoagulants.
    Ornetti P; Ciappuccini R; Tavernier C; Maillefert JF
    Rheumatology (Oxford); 2005 Dec; 44(12):1584-5. PubMed ID: 16204376
    [No Abstract]   [Full Text] [Related]  

  • 11. Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006.
    Boudal P; Sommet A; Bagheri H; Pathak A; Montastruc JL
    Therapie; 2010; 65(6):567-9. PubMed ID: 21176763
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin].
    Chouchana L; Languille E; Weiss N; Billaud EM; Lillo-Le Louet A
    Presse Med; 2013 May; 42(5):908-11. PubMed ID: 23069229
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute interstitial nephritis of fluindione: about three cases].
    Beauchamp C; Enache I; Haskour A; Martin L
    Nephrol Ther; 2008 Oct; 4(5):339-46. PubMed ID: 18417438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choose warfarin.
    Prescrire Int; 2013 Jun; 22(139):158. PubMed ID: 23866357
    [No Abstract]   [Full Text] [Related]  

  • 15. Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
    Gaertner S; Cordeanu EM; Mirea C; Stephan D
    Int J Cardiol; 2015; 186():141-2. PubMed ID: 25818758
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tramadol and oral anticoagulants: interaction or confounding factors?].
    Chiffoleau A; Veyrac G; Dudouet D; Miremont G; Merle L; David-Laroche M; Bourin M; Jolliet P
    Therapie; 2003; 58(5):471-4. PubMed ID: 14682201
    [No Abstract]   [Full Text] [Related]  

  • 17. Saw palmetto for prostate disorders.
    Gordon AE; Shaughnessy AF
    Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proven and unproven therapy for benign prostatic hyperplasia.
    DiPaola RS; Morton RA
    N Engl J Med; 2006 Feb; 354(6):632-4. PubMed ID: 16467551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Permixon in the treatment of benign prostatic hyperplasia].
    Gorilovskiĭ LM
    Ter Arkh; 1995; 67(8):62-4. PubMed ID: 7482341
    [No Abstract]   [Full Text] [Related]  

  • 20. What is saw palmetto used for, and does it interact with any medications?
    Gerber G
    Health News; 2000 Jun; 6(6):10. PubMed ID: 10917733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.